This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Levin, D. L. Articles by Weinberg, A. G. Search for Related Content PubMed PubMed Citation Articles by Levin, D. L. Articles by Weinberg, A. G.

Circulation, Vol 60, 360-364, Copyright © 1979 by American Heart Association

ARTICLES

Hemodynamic, pulmonary vascular, and myocardial abnormalities secondary to pharmacologic constriction of the fetal ductus arteriosus. A possible mechanism for persistent pulmonary hypertension and transient tricuspid insufficiency in the newborn infant

DL Levin, LJ Mills and AG Weinberg

The prostaglandin synthetase inhibitor indomethacin was given orally or intravenously to pregnant ewes. This resulted in a significant rise in the fetal pulmonary-to-systemic arterial mean blood pressure difference across the ductus arteriosus, presumably secondary to constriction of the ductus arteriosus. In five experiments the pressure difference could be promptly but temporarily reversed by the administration of prostaglandin E1 (PGE1) into the fetal inferior vena cava. Fetal lungs from study and control animals were fixed by perfusion at measured pulmonary arterial mean blood pressure, and fifth-generation resistance vessels were studied. The medial width/external diameter ratio was significantly increased in the study vs the control lungs due to increased smooth muscle and decreased external diameter. In addition, study fetuses had acute degenerative myocardial changes in the tricuspid valve papillary muscles, the right ventricular free wall and the interventricular septum. Similar changes were not seen in control fetuses. Indomethacin administration during pregnancy causes constriction of the fetal ductus arteriosus, fetal pulmonary arterial hypertension, and right ventricular damage. If severe, this may cause rapid fetal death. If less severe, in the newborn infant, this mechanism may be one cause of persistent pulmonary hypertension due to vasoconstriction and increased pulmonary arterial smooth muscle and/or tricuspid insufficiency due to papillary muscle infarction.

This article has been cited by other articles:

				M. A. Alano, E. Ngougmna, E. M. Ostrea Jr, and G. G. Konduri Analysis of Nonsteroidal Antiinflammatory Drugs in Meconium and Its Relation to Persistent Pulmonary Hypertension of the Newborn Pediatrics, March 1, 2001; 107(3): 519 - 523. [Abstract] [Full Text]

				Y. V. Maeno, S. A. Kamenir, B. Sinclair, M. E. van der Velde, J. F. Smallhorn, and L. K. Hornberger Prenatal Features of Ductus Arteriosus Constriction and Restrictive Foramen Ovale in d-Transposition of the Great Arteries Circulation, March 9, 1999; 99(9): 1209 - 1214. [Abstract] [Full Text] [PDF]

				A. M. Rudolph Effects of Aspirin and Acetaminophen in Pregnancy and in the Newborn Arch Intern Med, February 23, 1981; 141(3): 358 - 363. [Abstract] [PDF]

				A. M. Rudolph High Pulmonary Vascular Resistance After Birth: I. Pathophysiologic Considerations and Etiologic Classification Clinical Pediatrics, September 1, 1980; 19(9): 585 - 590. [Abstract] [PDF]